CD64 and HLA-DR, as well as the biomarker panels CD64/CD304 and HLA-DR/CD90/CD29, were found to be clearly discriminative between long-standing RA (or RA subgroups with mild or high current activity in synovitis) and acute non-RA arthritis. This evidence concerns the gene THY1 and Arthritis.